Viatris Believes Eylea Biosimilar Candidate Is First To Reach US FDA’s Desk

As Viatris Discloses ‘Challenging’ Orencia Biosimilar Is Part Of Pipeline Again

Eye
Viatris developed aflibercept with Momenta, now a part of J&J • Source: Shutterstock

More from Biosimilars

More from Products